Coya Therapeutics Inc. (COYA)
NASDAQ: COYA
· Real-Time Price · USD
5.48
-0.15 (-2.66%)
At close: Jun 16, 2025, 3:59 PM
5.47
-0.18%
After-hours: Jun 16, 2025, 06:22 PM EDT
-2.66% (1D)
| Bid | 5.46 |
| Market Cap | 91.65M |
| Revenue (ttm) | 3.69M |
| Net Income (ttm) | -17.14M |
| EPS (ttm) | -1.07 |
| PE Ratio (ttm) | -5.12 |
| Forward PE | -2.83 |
| Analyst | Buy |
| Ask | 6.53 |
| Volume | 19,058 |
| Avg. Volume (20D) | 59,574 |
| Open | 5.70 |
| Previous Close | 5.63 |
| Day's Range | 5.46 - 5.83 |
| 52-Week Range | 4.65 - 10.24 |
| Beta | 0.21 |
About COYA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol COYA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for COYA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+7.2%
Coya Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
7 months ago
-27.67%
Coya Therapeutics shares are trading lower. The company announced results from the placebo-controlled Phase 2 clinical trial of LD IL-2 in patients with mild to moderate Alzheimer's Disease.
1 month ago · businesswire.com
Coya Therapeutics to Participate in Two Upcoming Conferences in May 2025HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) fun...
